12,477 press releases in English indexed under finance.
The signature fundraising event aims to raise $150,000 to support women and families navigating breast cancer CHICAGO, Oct. 7, 2026 -- The tgin Foundation's 9th Annual Cocktails for the Cure Gala will take place on Saturday, October 10, 2026, from 6:00 p.m. to 10:00 p.m. at...
OMA SAVINGS BANK PLC, STOCK EXCHANGE RELEASE 7 OCTOBER 2026 AT 18.00 P.M. EEST, MAJOR SHAREHOLDER ANNOUNCEMENT
ARMONK, N.Y., October 7, 2026 / PRNewswire / -- IBM (NYSE: IBM ) will hold its quarterly conference call to discuss its third-quarter 2026 financial results on Wednesday, October 21, 2026 at 5:00 p.m. ET. The live webcast of the earnings call can be accessed at www.ibm.com/investor. Please also visit the investor website for the earnings press release prior to the webcast. A replay, associated charts and prepared rem
Parabolic (NASDAQ: PARA) expects Q3 2026 revenue of ~$4.7M, up 104% sequentially and 67% YoY, its first quarter including ConnectAndSell; unaudited.
CHICAGO, Oct. 07, 2026 -- Accel Entertainment, Inc. (NYSE: ACEL) (“Accel” or “the Company”), a leading locals-focused gaming operator partnering with small businesses, local communities, and state governments to provide entertaining, convenient, and safe gaming experiences nationwide, announced today that it will release its financial and operating results for the third quarter ended September 30, 2026, after market close on Tuesday, November 3, 2026. The Company will host a conference call and webcast that day at 4:30 PM ET / 3:30 PM CT to review the results.
TORONTO, Oct. 07, 2026 -- Fairfax Financial Holdings Limited (“Fairfax”) (TSX: FFH and FFH.U) announces that it has entered into agreements to partner with Wittington Investments, Limited (“Wittington”), the holding company of the Weston family based in Canada, to acquire from The Boots Group the Boots retail operations in the UK and Ireland, the Boots Opticians business, the No7 Beauty Company, and Boots’ Thailand and franchised businesses (collectively, “Boots”) for a total purchase price of approximately US$8.9 billion (inclusive of assumed debt) (the “Transaction”).
Hong Kong, Oct. 07, 2026 -- Click Holdings Limited (“Click Holdings” or “Click” or “we” or “us”, NASDAQ: CLIK) and its subsidiaries (collectively, the “Company”), a leader in human resources (“HR”) and senior care solutions in Hong Kong, today announced that Care U, its premium senior-care brand, is adding a live rehabilitation layer and becoming a more complete silver-economy platform. Through a new Hong Kong joint-venture company, Care U Rehabilitation Services Company Limited, an already-operating physiotherapy clinic will continue operating seamlessly as Care U Rehabilitation Centre, which serves as the Group’s Central Clinic (the “Central Clinic”).
HOUSTON – Oct. 7, 2026 – HPE (NYSE: HPE) today announced the first four of its HPE ProLiant Gen13 Servers powered by 6th Generation AMD EPYC™ Server processors. The new systems expand compute, memory, and I/O capabilities to help enterprises accelerate agentic AI and inference, analytics, virtualization, simulation, and modeling while strengthening security, simplifying operations, and providing reliability across distributed IT environments. As AI systems evolve from generating insights to taking autonomous action, trust becomes a prerequisite for scale. McKinsey’s 2026 AI Trust Maturity S...
AbbVie (NYSE: ABBV) today announced that the U.S. Food and Drug Administration (FDA) has granted two Breakthrough Therapy Designations (BTDs) for...
Received notice for upcoming USDA meetingCompany is reviewing strategic alternatives to monetize OS Animal Health ("OSAH")Grasonville, Maryland--(October 7, 2026) - OS Therapies, Inc. (NYSE American: OSTX) ("OS Therapies" or the "Company"), the world leader in gene-edited, Listeria-based cancer immunotherapies, today announced that its wholly-owned animal health subsidiary, OSAH received feedback from the U.S. Department of Agriculture (USDA) related to its submission to gain...
Data through 9 months of follow-up from this ongoing 36-month study demonstrate high vessel patency, low reintervention rates and meaningful improvements in mobility and symptoms, providing evidence supporting the treatment of complex iliac artery disease. BD (Becton, Dickinson and Company) (NYSE: BDX ), a leading global medical technology company, today announced positive nine-month results from th
Lipocine Inc. (NASDAQ: LPCN ), a specialty pharmaceutical company focused on the development of novel oral therapeutics, today announced that, through Lipocine's licensing partner Verity Pharmaceuticals Inc (Verity Pharma), Health Canada has approved TLANDO® (testosterone undecanoate) capsules for testosterone replacement therapy in adult males for the conditions associated with a deficiency or abse